ANNX
Price
$7.11
Change
-$0.09 (-1.25%)
Updated
Sep 16, 02:58 PM (EDT)
63 days until earnings call
FDMT
Price
$16.42
Change
+$0.17 (+1.05%)
Updated
Sep 16, 03:16 PM (EDT)
51 days until earnings call
Ad is loading...

ANNX vs FDMT

Header iconANNX vs FDMT Comparison
Open Charts ANNX vs FDMTBanner chart's image
Annexon
Price$7.11
Change-$0.09 (-1.25%)
Volume$100
CapitalizationN/A
4D Molecular Therapeutics
Price$16.42
Change+$0.17 (+1.05%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
ANNX vs FDMT Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ANNX vs. FDMT commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Buy and FDMT is a StrongBuy.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (ANNX: $7.20 vs. FDMT: $16.25)
Brand notoriety: ANNX and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 98% vs. FDMT: 40%
Market capitalization -- ANNX: $760.71M vs. FDMT: $844.51M
ANNX [@Biotechnology] is valued at $760.71M. FDMT’s [@Biotechnology] market capitalization is $844.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileFDMT’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • FDMT’s FA Score: 1 green, 4 red.
According to our system of comparison, ANNX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while FDMT’s TA Score has 3 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 4 bearish.
  • FDMT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than FDMT.

Price Growth

ANNX (@Biotechnology) experienced а +25.22% price change this week, while FDMT (@Biotechnology) price change was +7.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +4.67%, and the average quarterly price growth was -1.44%.

Reported Earning Dates

ANNX is expected to report earnings on Nov 18, 2024.

FDMT is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($845M) has a higher market cap than ANNX($761M). ANNX YTD gains are higher at: 58.590 vs. FDMT (-19.793). ANNX (-124.62M) and FDMT (-125.09M) have comparable annual earnings (EBITDA) . FDMT has more cash in the bank: 542M vs. ANNX (369M). FDMT has less debt than ANNX: FDMT (13.7M) vs ANNX (30.2M). FDMT has higher revenues than ANNX: FDMT (20.2M) vs ANNX (0).
ANNXFDMTANNX / FDMT
Capitalization761M845M90%
EBITDA-124.62M-125.09M100%
Gain YTD58.590-19.793-296%
P/E RatioN/AN/A-
Revenue020.2M-
Total Cash369M542M68%
Total Debt30.2M13.7M220%
TECHNICAL ANALYSIS
Technical Analysis
ANNXFDMT
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTSIX31.590.60
+1.94%
Invesco Small Cap Growth Inv
HDPBX24.640.17
+0.69%
Hodges Blue Chip Equity Income Retail
WLTTX11.690.06
+0.52%
Wilshire International Equity Instl
BRXCX13.540.05
+0.37%
MFS Blended Research Intl Eq C
FIDKX51.180.04
+0.08%
Fidelity International Discovery K

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with MGTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+6.98%
MGTX - ANNX
46%
Loosely correlated
+1.92%
FDMT - ANNX
41%
Loosely correlated
+2.14%
VIR - ANNX
40%
Loosely correlated
+3.18%
FULC - ANNX
40%
Loosely correlated
-7.56%
INZY - ANNX
39%
Loosely correlated
+6.76%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with ANNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.14%
ANNX - FDMT
41%
Loosely correlated
+6.98%
KPTI - FDMT
39%
Loosely correlated
+3.85%
ORMP - FDMT
38%
Loosely correlated
+5.51%
SCPH - FDMT
38%
Loosely correlated
+3.39%
KOD - FDMT
36%
Loosely correlated
+13.87%
More